rs200559481

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001164507.2(NEB):​c.23840T>G​(p.Leu7947Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000499 in 1,581,982 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.000085 ( 0 hom., cov: 32)
Exomes š‘“: 0.000046 ( 0 hom. )

Consequence

NEB
NM_001164507.2 missense

Scores

1
5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:1

Conservation

PhyloP100: 2.09

Publications

4 publications found
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
RIF1 (HGNC:23207): (replication timing regulatory factor 1) This gene encodes a protein that shares homology with the yeast teleomere binding protein, Rap1 interacting factor 1. This protein localizes to aberrant telomeres may be involved in DNA repair. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.21020311).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEBNM_001164507.2 linkc.23840T>G p.Leu7947Trp missense_variant Exon 167 of 182 ENST00000427231.7 NP_001157979.2
NEBNM_001164508.2 linkc.23840T>G p.Leu7947Trp missense_variant Exon 167 of 182 ENST00000397345.8 NP_001157980.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEBENST00000397345.8 linkc.23840T>G p.Leu7947Trp missense_variant Exon 167 of 182 5 NM_001164508.2 ENSP00000380505.3
NEBENST00000427231.7 linkc.23840T>G p.Leu7947Trp missense_variant Exon 167 of 182 5 NM_001164507.2 ENSP00000416578.2

Frequencies

GnomAD3 genomes
AF:
0.0000855
AC:
13
AN:
152004
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000177
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000786
AC:
19
AN:
241596
AF XY:
0.0000917
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000605
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000145
Gnomad OTH exome
AF:
0.000170
GnomAD4 exome
AF:
0.0000462
AC:
66
AN:
1429860
Hom.:
0
Cov.:
27
AF XY:
0.0000505
AC XY:
36
AN XY:
712402
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32546
American (AMR)
AF:
0.0000691
AC:
3
AN:
43430
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25930
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39420
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82740
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53116
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5700
European-Non Finnish (NFE)
AF:
0.0000533
AC:
58
AN:
1087682
Other (OTH)
AF:
0.0000675
AC:
4
AN:
59296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000855
AC:
13
AN:
152122
Hom.:
0
Cov.:
32
AF XY:
0.0000941
AC XY:
7
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41534
American (AMR)
AF:
0.00
AC:
0
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000177
AC:
12
AN:
67968
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.533
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000149
Hom.:
0
Bravo
AF:
0.0000907
ExAC
AF:
0.0000911
AC:
11
EpiCase
AF:
0.000220
EpiControl
AF:
0.000240

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Nemaline myopathy 2 Uncertain:3Benign:1
May 18, 2021
Pars Genome Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 22, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 28, 2024
Pittsburgh Clinical Genomics Laboratory, University of Pittsburgh Medical Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence variant is a single nucleotide substitution (T>G) at position 23945 of the coding sequence of the NEB gene that results in a leucine to tryptophan amino acid change at residue 7982 of the nebulin protein. This is a previously reported variant (ClinVar 465573) that has not been observed in the literature in individuals affected by NEB-related disorders, to our knowledge. This variant is present in 79 of 1581982 alleles (0.004994%) in the gnomAD v4.1.0 population dataset. Multiple bioinformatic tools predict that this amino acid change would be damaging, and the Leu7982 residue at this position is moderately conserved across the vertebrate species examined. Studies examining the functional consequence of this variant have not been published, to our knowledge. At this time, there is insufficient evidence to determine if this variant is pathogenic or benign. Therefore, we consider this a variant of uncertain significance. ACMG Criteria: BP1, BP4 -

Nov 11, 2019
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Apr 26, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.18737T>G (p.L6246W) alteration is located in exon 140 (coding exon 138) of the NEB gene. This alteration results from a T to G substitution at nucleotide position 18737, causing the leucine (L) at amino acid position 6246 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

NEB-related disorder Uncertain:1
Feb 21, 2024
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The NEB c.23945T>G variant is predicted to result in the amino acid substitution p.Leu7982Trp. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.013% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

not provided Uncertain:1
Dec 27, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
23
DANN
Benign
0.96
DEOGEN2
Benign
0.064
.;.;T;.;T;.;.;T
Eigen
Uncertain
0.22
Eigen_PC
Benign
0.10
FATHMM_MKL
Benign
0.58
D
LIST_S2
Benign
0.74
T;T;T;T;T;.;.;T
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.21
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.48
T
MutationAssessor
Pathogenic
3.2
M;.;.;.;M;.;.;.
PhyloP100
2.1
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-1.5
N;N;.;N;N;.;.;D
REVEL
Uncertain
0.35
Sift
Benign
0.036
D;T;.;D;D;.;.;T
Sift4G
Uncertain
0.0070
D;D;D;D;D;D;D;.
Polyphen
1.0
.;.;.;.;D;.;.;.
Vest4
0.65
MVP
0.62
MPC
0.42
ClinPred
0.30
T
GERP RS
4.4
Varity_R
0.090
gMVP
0.44
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200559481; hg19: chr2-152359395; API